The Drug Information Journal and the Drug Information Association
- PDF / 960,840 Bytes
- 1 Pages / 612 x 792 pts (letter) Page_size
- 71 Downloads / 187 Views
xi
F R O M THE EDITOR-IN-CHIEF
The Drug Infomution Journal and the Drug Informat ion Association Michael R. Hanrell, PhD Editor-in-Chief
The Drug Information Association has been a part of the publication of the regulation of drug products since its inception in 1964. As a professional association of nearly 20,000 members worldwide, DIA represents individuals who are involved in the discovery, development, regulation, surveillance, or marketing of pharmaceuticals or related products. One way DIA serves this mission is by publishing articles and meeting presentations on topics of timely interest to its members. The Drug Information Journal (DlJ)is now in its 41st year of publication as the official publication of the Drug Information Association. The journal is the leading peer-reviewed, scholarly publication that seeks to disseminate information on drug research, development, and information systems; to foster communication between educational, research, industrial, and governmental personnel engaged in drug information activities; and to provide a forum for developing improved methods of presenting research data generated from chemical, toxicologic, pharmacologic, and clinical studies and other topics important in drug development. DIA continues to be committed to the broad
dissemination of information among its members, with continuously improved professional practice as the goal. DIA serves its members in a neutral, global environment that operates independent of the influence of any one organization or authority. As part of this commitment, the DIA is pleased to announce that, starting with the January 2007 issue, the DlJ will publish six times per year. The journal will also publish special sections on focused topics that highlight key regulatory issues critical to the safe and timely development of new drugs. It will continue to offer medical and pharmacy education credits through the continuing education article that appears, along with the posttest and evaluation form, in each issue. This is all part of DIA's larger goal to provide an opportunity for career advancement and credit using DIA publications. As the journal's editor-in-chief, 1 am pleased to serve DIA and its members and to lead the journal in the tradition of offering opportunities for members to read and disseminate information critical to our role in drug development. The Drug Information Journal looks forward to publishing your informative and well-timed articles.
at NANYANG TECH UNIV LIBRARY on June 13, 2015 Drug Information Downloaded J d .from Vd.dij.sagepub.com 41. pg. xi. 2007 0092-8615/2007
Printed in the IISA. All rishts resewed. Cnnvrirht 0 2 0 7 DIUP lnfnnnotinn Asnoridinn. Inc.
Data Loading...
